Literature DB >> 10712197

Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.

R Fahsold1, S Hoffmeyer, C Mischung, C Gille, C Ehlers, N Kücükceylan, M Abdel-Nour, A Gewies, H Peters, D Kaufmann, A Buske, S Tinschert, P Nürnberg.   

Abstract

More than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene. For each patient, the whole coding sequence and all splice sites were studied for aberrations, either by the protein truncation test (PTT), temperature-gradient gel electrophoresis (TGGE) of genomic PCR products, or, most often, by direct genomic sequencing (DGS) of all individual exons. A total of 301 sequence variants, including 278 bona fide pathogenic mutations, were identified. As many as 216 or 183 of the genuine mutations, comprising 179 or 161 different ones, can be considered novel when compared to the recent findings of Upadhyaya and Cooper, or to the NNFF mutation database. Mutation-detection efficiencies of the various screening methods were similar: 47.1% for PTT, 53.7% for TGGE, and 54.9% for DGS. Some 224 mutations (80.2%) yielded directly or indirectly premature termination codons. These mutations showed even distribution over the whole gene from exon 1 to exon 47. Of all sequence variants determined in our study, <20% represent C-->T or G-->A transitions within a CpG dinucleotide, and only six different mutations also occur in NF1 pseudogenes, with five being typical C-->T transitions in a CpG. Thus, neither frequent deamination of 5-methylcytosines nor interchromosomal gene conversion may account for the high mutation rate of the NF1 gene. As opposed to the truncating mutations, the 28 (10.1%) missense or single-amino-acid-deletion mutations identified clustered in two distinct regions, the GAP-related domain (GRD) and an upstream gene segment comprising exons 11-17. The latter forms a so-called cysteine/serine-rich domain with three cysteine pairs suggestive of ATP binding, as well as three potential cAMP-dependent protein kinase (PKA) recognition sites obviously phosphorylated by PKA. Coincidence of mutated amino acids and those conserved between human and Drosophila strongly suggest significant functional relevance of this region, with major roles played by exons 12a and 15 and part of exon 16.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712197      PMCID: PMC1288164          DOI: 10.1086/302809

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  86 in total

1.  The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences.

Authors:  M Krawczak; J Reiss; D N Cooper
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

2.  NF1-related locus on chromosome 15.

Authors:  E Legius; D A Marchuk; B K Hall; L B Andersen; M R Wallace; F S Collins; T W Glover
Journal:  Genomics       Date:  1992-08       Impact factor: 5.736

3.  The BCR gene encodes a novel serine/threonine kinase activity within a single exon.

Authors:  Y Maru; O N Witte
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

Review 4.  Identification and characterization of the gene for neurofibromatosis type 1.

Authors:  R White; P O'Connell
Journal:  Curr Opin Genet Dev       Date:  1991-06       Impact factor: 5.578

5.  Translation initiation in the HEXB gene encoding the beta-subunit of human beta-hexosaminidase.

Authors:  K Neote; C A Brown; D J Mahuran; R A Gravel
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

6.  The neurofibromatosis type 1 gene encodes a protein related to GAP.

Authors:  G F Xu; P O'Connell; D Viskochil; R Cawthon; M Robertson; M Culver; D Dunn; J Stevens; R Gesteland; R White
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

7.  Somatic mutations in the neurofibromatosis 1 gene in human tumors.

Authors:  Y Li; G Bollag; R Clark; J Stevens; L Conroy; D Fults; K Ward; E Friedman; W Samowitz; M Robertson
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

8.  The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.

Authors:  G A Martin; D Viskochil; G Bollag; P C McCabe; W J Crosier; H Haubruck; L Conroy; R Clark; P O'Connell; R M Cawthon
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

9.  Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.

Authors:  T Sakai; J Toguchida; N Ohtani; D W Yandell; J M Rapaport; T P Dryja
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

10.  cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product.

Authors:  D A Marchuk; A M Saulino; R Tavakkol; M Swaroop; M R Wallace; L B Andersen; A L Mitchell; D H Gutmann; M Boguski; F S Collins
Journal:  Genomics       Date:  1991-12       Impact factor: 5.736

View more
  84 in total

1.  A cSNP map and database for human chromosome 21.

Authors:  S Deutsch; C Iseli; P Bucher; S E Antonarakis; H S Scott
Journal:  Genome Res       Date:  2001-02       Impact factor: 9.043

Review 2.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

3.  Molecular diagnosis of neurofibromatosis type 1: 2 years experience.

Authors:  Siân Griffiths; Peter Thompson; Ian Frayling; Meena Upadhyaya
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

4.  Reduced growth of Drosophila neurofibromatosis 1 mutants reflects a non-cell-autonomous requirement for GTPase-Activating Protein activity in larval neurons.

Authors:  James A Walker; Anna V Tchoudakova; Peter T McKenney; Suzanne Brill; Dongyun Wu; Glenn S Cowley; Iswar K Hariharan; André Bernards
Journal:  Genes Dev       Date:  2006-11-17       Impact factor: 11.361

5.  A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein.

Authors:  Igor D'Angelo; Stefan Welti; Fabien Bonneau; Klaus Scheffzek
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

6.  Genetic variability in a genomic region with long-range linkage disequilibrium reveals traces of a bottleneck in the history of the European population.

Authors:  Claudia Schmegner; Josef Hoegel; Walther Vogel; Günter Assum
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

7.  Novel mutations involving the NF1 gene coding sequence in neurofibromatosis type 1 patients from Taiwan.

Authors:  Ming-Tzen Liu; Jih-Shyun Su; Chun-Yu Huang; Shih-Feng Tsai
Journal:  J Hum Genet       Date:  2003-09-26       Impact factor: 3.172

8.  Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1.

Authors:  Doris Steinemann; Larissa Arning; Inka Praulich; Manfred Stuhrmann; Henrik Hasle; Jan Stary; Brigitte Schlegelberger; Charlotte M Niemeyer; Christian Flotho
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

9.  The Ras GTPase-activating protein neurofibromin 1 promotes the positive selection of thymocytes.

Authors:  Jennifer A Oliver; Philip E Lapinski; Beth A Lubeck; Jackson S Turner; Luis F Parada; Yuan Zhu; Philip D King
Journal:  Mol Immunol       Date:  2013-03-20       Impact factor: 4.407

10.  The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1.

Authors:  Seon-Yong Jeong; Sang-Jin Park; Hyon J Kim
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.